These articles focus on political debates surrounding healthcare funding and potential cuts, specifically addressing the NIH and Medicaid programs. The discussions involve scrutiny from Democrats and comparisons to past political rhetoric.
This headline discusses the FDA's plans to integrate artificial intelligence into the drug approval process, aiming to enhance efficiency.